Compounds > 8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate
Page last updated: 2024-11-05

8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate and Lymphoma, T-Cell

8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate has been researched along with Lymphoma, T-Cell in 1 studies

8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate: intracellular calcium antagonist; RN given refers to parent cpd

Lymphoma, T-Cell: A group of heterogeneous lymphoid tumors representing malignant transformations of T-lymphocytes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Roy, R1
Singh, SM1
Shanker, A1
Sodhi, A1

Other Studies

1 other study available for 8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate and Lymphoma, T-Cell

ArticleYear
Mechanism of thymocyte apoptosis induced by serum of tumor-bearing host: the molecular events involved and their inhibition by thymosin alpha-1.
    International journal of immunopharmacology, 2000, Volume: 22, Issue:4

    Topics: Animals; Apoptosis; Calcium; Culture Media, Conditioned; Female; Gallic Acid; Lymphoma, T-Cell; Male

2000